Abstract
The development of countermeasures to prevent and treat COVID-19 is a global health priority. In under 7 weeks, we enrolled a cohort of SARS-CoV-2-recovered participants, developed neutralization assays to interrogate serum and monoclonal antibody responses, adapted our high throughput antibody isolation, production and characterization pipeline to rapidly screen over 1000 antigen-specific antibodies, and established an animal model to test protection. We report multiple highly potent neutralizing antibodies (nAbs) and show that passive transfer of a nAb provides protection against high-dose SARS-CoV-2 challenge in Syrian hamsters. The study suggests a role for nAbs in prophylaxis, and potentially therapy, of COVID-19. The nAbs define protective epitopes to guide vaccine design.
Citations
Jun 17, 2020·Science·Johanna HansenChristos A Kyratsous
Jun 17, 2020·Science·Philip J M BrouwerMarit J van Gils
Jun 14, 2020·Nature Reviews. Immunology·Jonathan Abraham
Jul 1, 2020·Turkish Journal of Biology = Türk Biyoloji Dergisi·Murat TopuzoĞullariSerap Derman
Jun 28, 2020·Journal of Virology·John P Moore, P J Klasse
Sep 13, 2020·Viruses·Philip L TzouRobert W Shafer
Sep 3, 2020·Nature Communications·Adam S DingensJesse D Bloom
Oct 8, 2020·Critical Care : the Official Journal of the Critical Care Forum·Salleh N EhaidebAbderrezak Bouchama
Sep 10, 2020·Journal of Virology·Rebecca L BrocatoJay W Hooper
Nov 6, 2020·Nature Communications·Tânia F CustódioChristian Löw
Sep 19, 2020·British Journal of Biomedical Science·S SalvamaniA Rhodes
Jan 14, 2021·Nature Communications·Cyrielle FougerouxAdam F Sander
Aug 4, 2020·Clinical Chemistry and Laboratory Medicine : CCLM·Sebastian HörberAndreas Peter
Oct 17, 2020·Annual Review of Biophysics·Jiahui ChenGuo-Wei Wei
Jun 11, 2021·Frontiers in Molecular Biosciences·Sonia Beeckmans, Edilbert Van Driessche
Sep 2, 2021·Molecular Biology·A N VzorovA L Gintsburg